An exploratory proposal for a revision to the 14-day rule in the regulatory context of China.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 41349523.
- Also identified by DOI 10.1016/j.stem.2025.10.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent advances in human embryo culture and revised guidelines from the International Society for Stem Cell Research (ISSCR) give grounds for extending the 14-day limit. To prepare for any possible future change in China's regulation, we propose a path toward cautious extension with strict oversight, balancing scientific progress with ethical responsibility.
Medical subject headings
- Stem Cell Research
- Embryo Research